ROACH: I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I'm a 39-year-old man who is thinking about potentially getting one. -- Anon. ANSWER: Hepatitis B is a viral ...

Though they may seem like something from the future, these five cancer vaccines are available now. Here are details about who ...

Hexavalent, six-in-one vaccine can reduce spread of the disease and cut costs ANALYSIS | ESTHER NAKKAZI | Pertussis, or ...

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Dynavax (DVAX – Research Report). The associated price target ...

Of the vulnerable, not vaccinated or immune respondents, 58% and 62%, respectively, reported not having been offered a ...

hepatitis B and COVID-19 — under Part B (medical insurance) to treat exposure to a disease, Part D covers all vaccines to prevent illness that the Advisory Committee on Immunization Practices ...

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Market Share: Hep B achieved 44% total U.S. market share in Q3 2024 ... Dynavax Technologies Corp (NASDAQ:DVAX) is actively enrolling in a Phase 12 trial for its shingles vaccine program, with ...